Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Abdel Saci
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
JAMA Oncology
Cancer Research
Oncology
GOLPH3 Modulates mTOR Signalling and Rapamycin Sensitivity in Cancer
Nature
Multidisciplinary
Related publications
Systemic Therapy for Previously Untreated Advanced BRAF-mutated Melanoma: Navigating a Shifting Landscape
Immunotherapy
Oncology
Allergy
Immunology
Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated With Anti-Ctla-4 Antibodies: Association With Overall Survival?
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Dramatic Survival Benefit With Nivolumab in Melanoma
Cancer Discovery
Oncology
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
JAMA Oncology
Cancer Research
Oncology
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Frequency of Circulating CD8+CD73+T Cells Is Associated With Survival in Nivolumab-Treated Melanoma Patients
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Prolonged Survival of a Patient With Metastatic Leptomeningeal Melanoma Treated With BRAF Inhibition-Based Therapy: A Case Report
BMC Cancer
Cancer Research
Oncology
Genetics
Nivolumab Improves Survival for Patients With Advanced Lung Cancer
Cancer
Cancer Research
Oncology
